Bayer AG (Germany), Zoetis, Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Ceva Sante Animlae (France), Virbac SA (France), Boehringer Ingelheim (Germany), and Vetoquinol (France)
(PRWEB) September 24, 2014
The “Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectable, Sprays, Pour On, Spot On, Collars, Ear Tags), Animal (Dogs, Cats, Cattle, Pigs, Sheep & Goats) - Global Forecast to 2018”, analyses and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Browse 151 market data tables 41 figures spread through 306 pages and in-depth TOC on “Veterinary Parasiticides Market”
Early buyers will receive 10% customization on this report.
The market was valued at $6,509.1 million in 2013 and is expected to grow at a moderate CAGR of 5.4% from 2013 to 2018.
Ask for PDF Brochure at http://www.marketsandmarkets.com/pdfdownload.asp?id=258895412
The global animal parasiticides market has experienced steady growth in the past few years attributed to the rising awareness about zoonotic diseases; growing investment activities from governments, non-government agencies, and major market players; increasing demand for protein rich food; worldwide regulations for prevention of the spread of animal diseases; implementation of animal welfare acts in developed countries; availability of new broad spectrum parasiticides product offerings from key market players, and growing trend towards adoption of pet animals such as cats and dogs, especially in the developing countries across APAC and Latin American region. However, stringent regulations for approval of animal parasiticides, expensive and time consuming R&D activities to develop a new product, restrictions on the use of parasiticides in food producing animals, restriction on the use of some parasiticides in certain countries are some of the major challenges to the growth of the market during the forecast period of 2013 to 2018.
The global market is segmented by product type, animal type, and geography. It also discusses the key market drivers, restraints, and opportunities of this market and its sub markets.
In 2013, Europe was a major market in 2013 with a share of around 25% to 30% of the global market, followed by North America, Rest of the World, and Asia-Pacific. Increasing companion animal population coupled with the positive trend towards animal health spending has led to the large market share of the European and North American veterinary parasiticides market. However, the Asia-Pacific and Latin America regions represent the highest growth opportunity for the market during the forecast period of 2013 to 2018. The market in APAC and Latin America regions is expected to grow at a CAGR of 6% to 7% during the forecast period. The growth in this market is driven by increasing livestock and companion animal population in the region, growing awareness about animal health, and rising per capita expenditure on animal health.
The animal parasiticides market is broadly categorized into three segments as endoparasiticides, ectoparasiticides, and endectocides. The ectoparasiticides are very popular and widely used to treat ectoparasites such as ticks, mites, lice, and fleas, among others in animals such as cats, dogs as well as livestock animals. Hence, ectoparasiticides market is poised to grow at a higher CAGR of 5.5% from 2013 to 2018.
In 2013, food-producing animals accounted for nearly 79.1% of the demand for animal parasiticides products, globally. This segment will continue to lead the animal parasiticides market through 2018, mainly driven by the increasing number of farm animals and increased awareness towards the prevention of parasitic diseases in livestock animals.
For Further Inquiry Speak to Analyst at http://www.marketsandmarkets.com/speaktoanalyst.asp?id=258895412
Some major players in the animal parasiticides market are Merial (Sanofi) (France), Bayer AG (Germany), Zoetis, Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Ceva Sante Animlae (France), Virbac SA (France), Boehringer Ingelheim (Germany), and Vetoquinol (France), among others.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/pharmaceuticals
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets